Claims
- 1. A Tilted Channel Implant (TCI) system [300] for performing TCI operations [353′] on supplied production samples [150] having a gate structure [124] of directly or indirectly measured length and one or more sidewalls [144] of directly or indirectly measured thickness, said TCI system comprising:
(a) first error determining means [363] for determining an amount of error in each production sample between the measured sidewall thickness [swM] and a pre-defined, target sidewall thickness [swT]; and (b) energy adjustment means [303] for adjusting TCI energy in response to the amount of error [SwM-Swt] determined by said first error determining means, where said adjusting of TCI energy at least partially counters deviation in depth of TCI dopants [355] due to said sidewall thickness error.
- 2. The Tilted Channel Implant (TCI) system [300] of claim 1 and further comprising:
(c) second error determining means [361] for determining an amount of error in each production sample between the measured gate length [L2M] and a pre-defined, target gate length [L2T]; and (d) dosage adjustment means [303] for adjusting TCI dosage in response to the amount of error determined by said second error determining means, where said adjusting of TCI dosage at least partially counters deviation in lateral distribution of TCI dopants [355] due to said gate length error.
- 3. The Tilted Channel Implant (TCI) system [300] of claim 2 wherein:
(a.1) said measured sidewall thickness [swM] is defined at least in part by measuring a pre-trim film thickness [FW] of a material [132] that is deposited to define said one or more sidewalls [144].
- 4. The Tilted Channel Implant (TCI) system [300] of claim 2 wherein:
(a.1) said measured sidewall thickness [SwM] is defined at least in part by measuring a post-trim film thickness of a material [132] that is deposited and thereafter trimmed to define said one or more sidewalls [144].
- 5. The Tilted Channel Implant (TCI) system [300] of claim 2 wherein said energy adjustment means [303] includes:
(b.1) energy adjustment interpolating means [450] for interpolating approximate energy adjustments based on two or more empirically established energy adjustments [EH,EL].
- 6. The Tilted Channel Implant (TCI) system [300] of claim 5 wherein said energy adjustment interpolating means [450] includes:
(b.1a) linear or quasi-linear energy adjustment interpolating means [451,452] for interpolating approximate energy adjustments in accordance with a formula of the form: Energya=E0*(1+βeSW/SWT) wherein E0 is a prespecified amount of implant energy used when sidewall thickness error eSw is zero, wherein said multiplying factor, β may either be a constant or a function of a specified windowing range of the normalized error, eSw/SwT, and where SwT is said target sidewall thickness.
- 7. The Tilted Channel Implant (TCI) system [300] of claim 6 wherein said multiplying factor, β is defined as one or more values selected from the range, 0.05≦β≦0.15 where the selected value depends on the sign of eSw/SwT.
- 8. The Tilted Channel Implant (TCI) system [300] of claim 5 wherein said dosage adjustment means [303] includes:
(d.1) dosage adjustment interpolating means [460,470] for interpolating approximate dosage adjustments based on two or more empirically established implant dosage adjustments [DH,DL].
- 9. The Tilted Channel Implant (TCI) system [300] of claim 8 wherein said dosage adjustment interpolating means includes:
(b.1a) linear or quasi-linear energy adjustment interpolating means for interpolating approximate energy adjustments in accordance with a formula of the form: Dosea=Dose0*(1+α((L2T−L2M)//L2T) wherein Dose0 is a prespecified amount of implant dosage used when gate length error L2T-L2M is zero, wherein said second multiplying factor, a may either be a constant or a function of a specified windowing range of the normalized error, (L2T−L2M)/L2T, where L2T is said target gate length and where L2M is said measured gate length.
- 10. The Tilted Channel Implant (TCI) system [300] of claim 9 wherein said second multiplying factor, α is defined as one or more values selected from the range, 0.05≦α≦0.15 where the selected value or values for α may depend on the sign and/or windowed magnitude of (L2T−L2M)/L2T.
- 11. The Tilted Channel Implant (TCI) system [300] of claim 1 wherein said energy adjustment means [303] includes:
(b.1) energy adjustment interpolating means [450] for interpolating approximate energy adjustments based on two or more empirically established energy adjustments [EH,EL].
- 12. The Tilted Channel Implant (TCI) system [300] of claim 11 wherein said energy adjustment interpolating means [450] includes:
(b.1a) linear or quasi-linear energy adjustment interpolating means [451,452] for interpolating approximate energy adjustments in accordance with a formula of the form: Energya=E0*(1+β*eSw/SwT) wherein E0 is a prespecified amount of implant energy used when sidewall thickness error eSw is zero, wherein said multiplying factor, β may either be a constant or a function of a specified windowing range of the normalized error, eSw/SwT, and where SwT is said target sidewall thickness.
- 13. A machine-implemented method for performing Tilted Channel Implant (TCI) operations [353′] on supplied production samples [150] having a gate structure [124] of directly or indirectly measured length and one or more sidewalls [144] of directly or indirectly measured thickness, said method comprising the steps of:
(a) first determining [363] an amount of first error in one or more production samples between the measured sidewall thickness [swM] and a pre-defined, target sidewall thickness [swT]; and (b) adjusting TCI energy in response to the amount of first error [swM-SwT] determined by said first determining step, where said adjusting of TCI energy at least partially counters deviation in depth of TCI dopants [355] due to said sidewall thickness error.
- 14. The machine-implemented TCI method of claim 13 and further comprising:
(c) second determining [361] an amount of respective second error in said one or more production samples between the measured gate length [L2M] and a pre-defined, target gate length [L2T]; and (d) adjusting TCI dosage in response to the amount of second error determined by said second error determining step, where said adjusting of TCI dosage at least partially counters deviation in lateral distribution of TCI dopants [355] due to said gate length error.
- 15. The machine-implemented TCI method of claim 14 wherein:
(a.1) said measured sidewall thickness [SwM] is defined at least in part by measuring a pre-trim film thickness [Fw] of a material [132] that is deposited to define said one or more sidewalls [144].
- 16. The machine-implemented TCI method of claim 14 wherein:
(a.1) said measured sidewall thickness [swM] is defined at least in part by measuring a post-trim film thickness of a material [132] that is deposited and thereafter trimmed to define said one or more sidewalls [144].
- 17. The machine-implemented TCI method of claim 14 wherein said energy adjusting step includes:
(b.1) interpolating [450] approximate energy adjustments based on two or more empirically established energy adjustments [EH,EL].
- 18. The machine-implemented TCI method of claim 17 wherein said energy adjustment interpolating step [450] includes:
(b.1a) using linear or quasi-linear energy adjustment interpolation [451,452] for interpolating approximate energy adjustments in accordance with a formula of the form: Energya=E0*(1+βeSw/SwT) wherein E0 is a prespecified amount of implant energy used when sidewall thickness error eSw is zero, wherein said multiplying factor, β may either be a constant or a function of a specified windowing range of the normalized error, eSw/SwT, and where SwT is said target sidewall thickness.
- 19. The machine-implemented TCI method of claim 18 wherein said multiplying factor, β is defined as one or more values selected from the range, 0.05≦β≦0.15 where the selected value depends on the sign of eSw/SwT.
- 20. The machine-implemented TCI method of claim 14 wherein said dosage adjusting step [303] includes:
(d.1) using dosage adjustment interpolation [460,470] for interpolating approximate dosage adjustments based on two or more empirically established implant dosage adjustments [DH,DL].
- 21. The machine-implemented TCI method of claim 20 wherein said dosage adjustment interpolating step includes:
(b.1a) using linear or quasi-linear energy adjustment interpolation for interpolating approximate energy adjustments in accordance with a formula of the form: Dosea=Dose0* (1+α(L2T−L2M)/L2T) wherein Dose0 is a prespecified amount of implant dosage used when gate length error L2T−L2M is zero, wherein said second multiplying factor, α may either be a constant or a function of a specified windowing range of the normalized error, (L2T−L2M)/L2T, where L2T is said target gate length and where L2M is said measured gate length.
- 22. The machine-implemented TCI method of claim 21 wherein said second multiplying factor, α is defined as one or more values selected from the range, 0.05≦α≦0.15 where the selected value or values for α may depend on the sign and/or windowed magnitude of (L2T−L2M)/L2T. (claims 1-22 of parent case are canceled in this divisional)
- 23. A computer system [301-303] for use in a mass production stream wherein upstream production samples [150] each have at least one of a gate structure [124] of directly or indirectly measured length and one or more adjacent gate sidewalls [144] of directly or indirectly measured thickness, and wherein production results [Leff] of downstream production steps [352] are affected by said at least one of the gate structure length [L2′] and the one or more gate sidewall thicknesses [Sw], said computer system comprising:
(a) error determining means [360] for determining one or more corresponding amounts of error in one or more production samples between the measured sidewall thickness [SwM] and a pre-specified, target sidewall thickness [SwT] or between the measured gate length [L2M] and a pre-defined, target gate length [L2T]; (b) error signal forwarding means [362,364] for feeding forward error signals representing said corresponding amounts of error; and (c) downstream compensating means [303,352] for receiving said fed forward error signals and for post-compensating for errors, if any, indicated by the fed forward error signals.
- 24. The computer system [301-303] of claim 23 wherein said downstream compensating means includes:
(c.1) a Tilted Channel Implant (TCI) subsystem [352] having at least one of variable implant energy parameter and a variable implant dosage parameter, where at least one of said implant parameters is responsive to at least one of said fed forward error signals.
- 25. The computer system [301-303] of claim 24 wherein said error determining means [360] includes:
(a.1) first error determining means [363] for determining a first amount of error in one or more production samples between respective measured sidewall thicknesses [SwM] and the pre-specified, target sidewall thickness [swT].
- 26. The computer system [301-303] of claim 25 wherein said error determining means [360] includes:
(a.2) second error determining means [361] for determining a second amount of error in one or more production samples between respective measured gate lengths [L2M] and the pre-defined, target gate length [L2T].
- 27. The computer system [301-303] of claim 24 wherein said downstream compensating means includes:
(c.2) energy parameter adjustment calculating means for defining adjustments to said variable implant energy parameter using an interpolation [450] based on one or more empirically established energy adjustments [EH,EL].
- 28. The computer system [301-303] of claim 27 wherein (c.2a) said energy adjustment interpolation [450] uses linear or quasi-linear energy adjustment interpolation [451,452] for interpolating approximate energy adjustments in accordance with a formula of the form:
- 29. The computer system [301-303] of claim 28 wherein said multiplying factor, β is defined as one or more values selected from the range, 0.05≦β≦0.15.
- 30. The computer system [301-303] of claim 24 wherein said downstream compensating means includes:
(c.2) dosage parameter adjustment calculating means for defining adjustments to said variable implant dosage parameter using an interpolation [460] based on one or more empirically established dosage adjustments [DH,DL].
- 31. The computer system [301-303] of claim 30 wherein
(c.2a) said dosage adjustment interpolation [460] uses linear or quasi-linear dosage adjustment interpolation for interpolating approximate dosage adjustments in accordance with a formula of the form: Dosea=Dose0*(1+α((L2T−L2M)/L2T) wherein Dose0 is a prespecified amount of implant dosage used when gate length error L2T−L2M is zero, wherein said second multiplying factor, a may either be a constant or a function of a specified windowing range of the normalized error, (L2T−L2M)/L2T, where L2T is said target gate length and where L2M is derived from one or more measured gate lengths.
- 32. The machine-implemented TCI method of claim 31 wherein said second multiplying factor, α is defined as one or more values selected from the range, 0.05≦α≦0.15.
- 33. An instructions conveying article for conveying instructions to a compatible and configurable computer system [301-303], where said computer system is for use in a mass production stream wherein upstream production samples [150] each have at least one of a gate structure [124] of directly or indirectly measured length and one or more adjacent gate sidewalls [144] of directly or indirectly measured thickness, and wherein production results [Leff] of downstream production steps [352] are affected by said at least one of the gate structure length [L2′] and the one or more gate sidewall thicknesses [Sw], said conveying instructions causing the computer system to perform the steps of:
(a) determining [360] one or more corresponding amounts of error in one or more production samples between the measured sidewall thickness [SwM] and a pre-specified, target sidewall thickness [se] or between the measured gate length [L2M] and a pre-defined, target gate length [L2T]; and (b) feeding forward [362,364] error signals representing said corresponding amounts of error to a downstream compensating means [303,352], where said downstream compensating means post-compensates for errors, if any, indicated by the fed forward error signals.
- 34. An improved, second mass production process [500] for producing integrated circuit devices [150] each having, in a first product-precursor form [140], at least one of a gate structure [124] of directly or indirectly measured length and one or more adjacent gate sidewalls [144] of directly or indirectly measured thickness, and wherein production results [Leff] of downstream production steps [352], where the production results are derived from the first product-precursor form [140], are affected by said at least one of the gate structure length [L2′] and the one or more gate sidewall thicknesses [sw] of the first product-precursor form,
wherein the improvement is over a first mass production process and the first mass production process is characterized by at least below aspects (1.1) and (1.5) as well as by at least one or the other of aspects (1.3) and (1.4):
(1.1) a first predefined one [510] of first process tolerance ranges, the first predefined range being applicable to a second product-precursor form [100] and being denoteable as e1<eGatePR≦e2, where eGatePR=LPRT-CDPRT, represents a difference between an ideal length, LPRT and a correspondingly measured length, CDPRT, for a developed photoresist feature [118,119], of the second product-precursor form [100], either before or after a PR trimming process [512] is carried out on said developed photoresist feature, and the first mass production process is further characterized by a deeming as out of tolerance [516], those measured specimens of the second product-precursor form whose measured length, CDPRT, causes eGatePR to be outside said first predefined range; (1.2) a second predefined one [520] of first process tolerance ranges, the second predefined range being applicable to a third product-precursor form [120] and being denoteable as e3≦eGateEtched≦e4 where eGateEtched=L2′T−L2′M, represents a difference between an ideal length, L2′T and a correspondingly measured length, L2′M, for an etched gate feature [124] of the third product-precursor form [120], and the first mass production process is further characterized by a deeming as out of tolerance [526], those measured specimens of the third product-precursor form whose measured length, L2′M causes eGateEtched to be outside said second predefined range; (1.3) a third predefined one [530] of first process tolerance ranges, the third predefined range being applicable to a fourth product-precursor form [130] and being denoteable as e5≦eDepo≦e6 where eDepo=FwT−FwM represents a difference between an ideal deposition thickness, FwT and a correspondingly measured deposition thickness, FwM, for a sidewall precursor film [132], of the fourth product-precursor form [130], and the first mass production process is further characterized by a deeming as out of tolerance [536], those measured specimens of the fourth product-precursor form whose measured deposition thickness, FwM causes eDepo to be outside said third predefined range; (1.4) a fourth predefined one [540] of first process tolerance ranges, the fourth predefined range being applicable to a fifth product-precursor form [140] and being denoteable as e7≦eSW—trim≦e8 where eSW—trim=SwM−SwT represents a difference between an ideal post sidewall-trim thickness, SwT and a correspondingly measured post sidewall-trim thickness, SwM, for one or more trimmed sidewalls [144] of the fifth product-precursor form [140], and the first mass production process is further characterized by a deeming as out of tolerance [546], those measured specimens of the fifth product-precursor form whose measured post sidewall-trim thickness, SwM causes eSW—trim to be outside said fourth predefined range; (1.5) a Tilted Channel Implant (TCI) [552] performed on the first product-precursor form after at least one of said etched gate feature [124] and said one or more trimmed sidewalls [144] are formed; said improved, second mass production process [500] being characterized by:
(a) adjusting [550] at least one of TCI energy and TCI dosage in response to deviation from a corresponding ideal dimension as detected by a corresponding one or more of said production measurement steps in corresponding ones of characterization aspects (1.1)-(1.5); and (b) a set of second process tolerance ranges, wherein at least one of the tolerance ranges in the second set is wider than a corresponding tolerance range in the first set.
- 35. The improved, second mass production process [500] of claim 34 wherein said adjusting of the TCI includes automatic adjusting of TCI energy in response to deviation in sidewall thickness using an interpolation [450] based on one or more empirically established energy adjustments [EH,EL].
- 36. The improved, second mass production process [500] of claim 35 wherein
said energy adjustment interpolation [450] uses linear or quasi-linear energy adjustment interpolation [451,452] for interpolating approximate energy adjustments in accordance with a formula of the form: Energya=E0*(1+β*eSw/SwT) wherein E0 is a prespecified amount of implant energy used when sidewall thickness error eSw is zero, wherein said multiplying factor, β may either be a constant or a function of a specified windowing range of the normalized error, eSw/SwT.
- 37. The improved, second mass production process [500] of claim 34 wherein said adjusting of the TCI includes automatic adjusting of TCI dosage in response to deviation in gate length using an interpolation [460] based on one or more empirically established energy adjustments [DH,DL].
- 38. The improved, second mass production process [500] of claim 37 wherein
said dosage adjustment interpolation [460] uses linear or quasi-linear dosage adjustment interpolation for interpolating approximate dosage adjustments in accordance with a formula of the form: Dosea=Dose0*(1+α(L2T−L2M)/L2T) wherein Dose0 is a prespecified amount of implant dosage used when gate length error L2T−L2M is zero, wherein said second multiplying factor, a may either be a constant or a function of a specified windowing range of the normalized error, (L2T−L2M)/L2T, where L2T is said target gate length and where L2M is derived from one or more measured gate lengths.
- 39. The improved, second mass production process [500] of claim 34 wherein said first mass production process is characterized by aspect (1.2).
- 40. The improved, second mass production process [500] of claim 39 wherein under-etched specimens of the third product-precursor form are further etched [528] and remeasured for error.
- 41. The improved, second mass production process [500] of claim 34 wherein over-deposited specimens of the of the fourth product-precursor form are exposed to a compensating, isotropic pre-etch [538] before said sidewalls are formed by anisotropic trimming [542].
CROSS-REFERENCE TO CO-OWNED PATENT APPLICATIONS
[0001] This application is a concurrent continuation-in-part of U.S. patent application Ser. No. _______, which application is owned by the owner of the present application and which application is concurrently filed herewith on behalf of the same inventors, Zoran Krivokapic and William D. Heavlin, and which parent application is initially entitled FEED-FORWARD CONTROL OF TCI DOPING FOR IMPROVING MASS-PRODUCTION-WISE, STATISTICAL DISTRIBUTION OF CRITICAL PERFORMANCE PARAMETERS IN SEMICONDUCTOR DEVICES, and whose disclosure is incorporated herein by reference.